Atlas Trials

Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer

Clinical trial NCT00688415 · COMPLETED

Trial details

NCT number
NCT00688415
Sponsor
Celgene
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid TumorsLymphoma
Start date
2008-11-07
Primary completion
2010-08-01
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.